NPRA - Announcement http://npra.moh.gov.my Wed, 19 Sep 2018 03:06:25 +0800 Open Source Excellence RSS Feeder en-gb Latihan TMHS – Product Quality Review (PQR) Dan Verifikasi http://npra.moh.gov.my/index.php/announcement/1347-latihan-tmhs-product-quality-review-pqr-dan-verifikasi http://npra.moh.gov.my/index.php/announcement/1347-latihan-tmhs-product-quality-review-pqr-dan-verifikasi

 

Latihan TMHS – Product Quality Review (PQR) Dan Verifikasi

Date: 21 - 22 November 2018 (Rabu dan Khamis)

Venue: Royale Chulan Damansara, Petaling Jaya

 

 

MASA:

8.30 pagi – 5.00 petang

OBJEKTIF LATIHAN:

  • Meningkatkan pemahaman pihak pengilang TMHS berkenaan keperluan PQR dan Verifikasi.
  • Menyampaikan ‘expectation’ pihak regulatori berkenaan pelaksanaan PQR dan Verifikasi

PENYERTAAN DIBUKA KEPADA:

Pengilang Tradisional (TM) dan Suplemen
Kesihatan (HS) di Malaysia.
• Tarikh penutupan penyertaan: 15 Nov 2018

 

 


  REGISTER HERE

 


 

drgd 
  DOWNLOAD FLIER


{pdf=http://npra.moh.gov.my/images/Announcement/2018/tmhsseminar/FlyerISPEPQRforTMHSNov2018v2.pdf|1120|1160|google}

]]>
jauze16@gmail.com (Jauze) Tue, 18 Sep 2018 12:20:00 +0800
Promosi Penjualan Monograf Herba Malaysia 2015 http://npra.moh.gov.my/index.php/announcement/1346-promosi-penjualan-monograf-herba-malaysia-2015 http://npra.moh.gov.my/index.php/announcement/1346-promosi-penjualan-monograf-herba-malaysia-2015 PROMOMHM2015forNRC201812092018

]]>
jauze16@gmail.com (Jauze) Tue, 18 Sep 2018 10:56:09 +0800
NRC 2018 Post Conference Seminar on WHO Good Practices for Desk Assessment for Compliance with GMP / GCP /GLP http://npra.moh.gov.my/index.php/announcement/1345-nrc-2018-post-conference-seminar-on-who-good-practices-for-desk-assessment-for-compliance-with-gmp-gcp-glp http://npra.moh.gov.my/index.php/announcement/1345-nrc-2018-post-conference-seminar-on-who-good-practices-for-desk-assessment-for-compliance-with-gmp-gcp-glp

 

NRC 2018 – Post Conference Seminar 2018 : WHO Good Practices for Desk Assessment for Compliance with GMP/GCP/GLP

Date: 4 October 2018 (2.00 pm – 5.15 pm)

Venue: Suria on 12, Hotel Royale ChulanDamansara

 

SPEAKER:

Dr. Vimal Sachdeva
Technical Officer (Senior Inspector)
World Health Organisation

OBJECTIVES:
To introduce the concept of Desk Assessment for compliance with GMP/GCP/GLP.

WHO SHOULD ATTEND:

Manufacturers, Importers,
Regulatory Affairs Managers/Executives, Product Registration Holder,
Product Owners.

 

Closing Date : 1 October 2018.

 

 


  REGISTER HERE

 


 

drgd 
  DOWNLOAD FLIER


{pdf=http://npra.moh.gov.my/images/Announcement/2018/seminar/FlyerNRCPostConference_Oct2018_2.pdf|1120|1160|google}

]]>
jauze16@gmail.com (Jauze) Tue, 18 Sep 2018 08:20:00 +0800
API Seminar 2018 http://npra.moh.gov.my/index.php/announcement/1344-api-seminar-2018 http://npra.moh.gov.my/index.php/announcement/1344-api-seminar-2018

 

API Seminar 2018

Date: 6 October 2018 (8.30 am – 5.00 pm)

Venue: Eastin Hotel, Petaling Jaya

 

INTRODUCTION:
In conjunction with the NRC 2018, this API Seminar is organised by the Pharmaceutical Association of Malaysia (PhAMA) and supported by the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health,for more in-depth understanding on Active Pharmaceutical Ingredient (API)Dossier Preparation and Regulatory Requirements.

SEMINAR OBJECTIVES:
The objectives of this seminar are:
• to understand clearly the dossier requirements for API dossier submission
• learn how to reduce deficiencies queries, and 
• how to meet the regulatory agency’s expectations

WHO SHOULD ATTEND:
• Regulatory staff involved in preparing documents and submission of dossiers for API Information.
• Anyone seeking a good understanding of regulatory control of API
• Product Registration Holders (PRH) /applicants and Regulatory Managers/Executives are encouraged to attend this seminar.

Participation is on a first-come-first-served basis and registration will close by 16 September 2018.

 

 


  REGISTration FORM

 


 

drgd 
  DOWNLOAD FLIER


{pdf=http://npra.moh.gov.my/images/Announcement/2018/api-seminar/APISeminar06Oct_Flyer.pdf|1120|1160|google}

]]>
jauze16@gmail.com (Jauze) Fri, 07 Sep 2018 08:20:00 +0800
2018 Education Seminar Series: Analysis of Findings from GMP Inspections of Pharmaceutical Manufacturers & Introduction to ‘Guidance Document of Pre-Approval GMP Inspection http://npra.moh.gov.my/index.php/announcement/1343-2018-education-seminar-series-analysis-of-findings-from-gmp-inspections-of-pharmaceutical-manufacturers-introduction-to-guidance-document-of-pre-approval-gmp-inspection http://npra.moh.gov.my/index.php/announcement/1343-2018-education-seminar-series-analysis-of-findings-from-gmp-inspections-of-pharmaceutical-manufacturers-introduction-to-guidance-document-of-pre-approval-gmp-inspection

 

2018 Education Seminar Series:

Analysis of Findings from GMP Inspections of Pharmaceutical Manufacturers & Introduction to ‘Guidance Document of Pre-Approval GMP Inspection

 

17 October 2018 (Wednesday) | 9.30 am – 4.00 pm

Venue :

THE ROYALE CHULAN DAMANSARA HOTEL, Petaling Jaya

 

Who should attend

Manufacturers and relevant personnel in various departments in pharmaceutical industry.

 

Objectives

  1. To share with the industry the analysis of findings from GMP inspections of pharmaceutical manufacturers.
  2. To enhance the understanding of GMP requirements in pharmaceutical manufacturers
  3. To introduce a new document by NPRA – ‘Guidance document of Pre-approval GMP Inspection’
  4. A platform for sharing GMP inspection related issues between NPRA and industry

 

 


  REGISTER HERE

 


 

drgd 
  DOWNLOAD FLIER


{pdf=http://npra.moh.gov.my/images/Announcement/2018/FlyerISPE_GMPAuditFindings17Oct2018_FINAL2.pdf|1120|1160|google}

]]>
jauze16@gmail.com (Jauze) Wed, 05 Sep 2018 08:20:03 +0800
Penyerahan Laporan Kajian Bioekuivalens (BE) Bagi Produk-Produk Generik Berdaftar Dalam Bentuk Effervescent, Dispersible, Orodispersible, Sublingual, Buccal Dan Chewable Tablet/Kapsul Untuk Tujuan Pendaftaran Semula [Direktif - Bil (27) dlm BPFK/PPP/07/25 http://npra.moh.gov.my/index.php/announcement/1342-penyerahan-laporan-kajian-bioekuivalens-be-bagi-produk-produk-generik-berdaftar-dalam-bentuk-effervescent-dispersible-orodispersible-sublingual-buccal-dan-chewable-tablet-kapsul-untuk-tujuan-pendaftaran-semula-direktif-bil-27-dlm-bpfk-ppp-07-25 http://npra.moh.gov.my/index.php/announcement/1342-penyerahan-laporan-kajian-bioekuivalens-be-bagi-produk-produk-generik-berdaftar-dalam-bentuk-effervescent-dispersible-orodispersible-sublingual-buccal-dan-chewable-tablet-kapsul-untuk-tujuan-pendaftaran-semula-direktif-bil-27-dlm-bpfk-ppp-07-25 Sila ambil perhatian bahawa laporan kajian BE untuk tujuan pendaftaran semula HANYA perlu dikemukakan kepada pihak NPRA dalam tempoh enam (6) hingga dua belas (12) bulan sebelum tamatnya tempoh sah pendaftaran produk. Ini adalah untuk menyeragamkan proses kerja NPRA, dan juga untuk memastikan bahawa penilaian laporan kajian BE adalah selaras dengan proses pendaftaran semula produk-produk generik tersebut.  

 

[Directive –Bil (27) dlm BPFK/PPP/07/25]
[Directive –Bil (45) dlm BPFK/PPP/01/03]

]]>
jauze16@gmail.com (Jauze) Mon, 03 Sep 2018 08:38:31 +0800
Updates on Bioequivalence (BE) Webpage (August 2018): Immediate Release Solid Oral Dosage Form http://npra.moh.gov.my/index.php/announcement/1339-updates-on-bioequivalence-be-webpage-august-2018-immediate-release-solid-oral-dosage-form http://npra.moh.gov.my/index.php/announcement/1339-updates-on-bioequivalence-be-webpage-august-2018-immediate-release-solid-oral-dosage-form 1. Application Forms and Checklist

i) Application For Biopharmaceutics Classification System (BCS) Biowaiver

ii) Application For A Biowaiver: Additional Strength

iii) Bioequivalence Study Report Submission Checklist

 

2. New Active Ingredients Listed in the Product Comparator List

No

Active Ingredient

Comparators

Manufacturer

1

Co-Dergocrine Mesylate

Hydergine Tablet 1mg
MAL19870102A

Hydergine Tablet 1.5mg
MAL19870106A

Hydergine Tablet 4.5mg
MAL19870111A

Novartis Farma S.P.A., Italy

 

Novartis Pharma AG, Switzerland

 

Novartis Pharma AG, Switzerland

2

Fimasartan Potassium Trihydrate

Kanarb Film-Coated Tablet 60mg
MAL8026063ARZ

Kanarb Film-Coated Tablet 120mg
MAL18026065ARZ

Boryung Pharmaceutical Co Ltd, South Korea

3

Ibuprofen Lysine

Nurofen Express 342mg Caplet
MAL13085058AZ

Nurofen Express 684mg Caplet
MAL13085061AZ

Reckitt Benckiser Healthcare International, United Kingdom

Reckitt Benckiser Healthcare International, United Kingdom

4

Piroxicam-B-Cyclodextrin

Brexin Tablet
MAL19992991AZ

Chiesi Farmaceutici S.P.A., Italy

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3. Additional Comparators Added to the Existing Comparator List

No

Active Ingredient

Additional Comparators

Manufacturer

1

Fenofibrate

Lipanthyl Capsule 300mg
(MAL19930138A)

Labs Fournier, France

2

Ibuprofen

Nurofen Express 200mg Liquid Capsules
(MAL18016015ACRZ)

Nurofen Express 400mg Liquid Capsules
(MAL18016016ACRZ)

Patheon Softgels B.V., Netherlands

 

Patheon Softgels B.V., Netherlands

3

Pravastatin

Apo-Pravastatin 20mg Tablet
(MAL20040229ARZ)

Apo-Pravastatin 40mg Tablet
(MAL06030825AZ)

Apotex Inc, Canada

 

Apotex Inc, Canada

4

Thioguanine

Lanvis Tablets 40mg
(MAL13065045ACZ)

Excella GmbH & Co. Kg, Germany

 

4. Additional Manufacturing Site added to Existing Comparator List

No

Active Ingredient

Comparator List

Product Name

Additional Manufacturing Site

1

Amlodipine

6th

Norvasc Tablet 5mg

Norvasc Tablet 10mg

Pfizer Pharmaceuticals LLC, United States

2

Atazanavir

ARV

Reyataz Capsule 100mg

Reyataz Capsule 150mg

Reyataz Capsule 200mg

AstraZeneca Pharmaceuticals LP, United States

3

Drospirenone 3mg + Ethinyl Estradiol 30mcg

FDC

Yasmin Tablet

Bayer Weimar GmbH und Co. KG, Germany

4

Entecavir

BE

Baraclude Tablet 0.5mg

AstraZeneca Pharmaceuticals LP, United States

5

Naltrexone Hydrochloride

BE

Revia Tablet 50mg

Bristol-Myers Squibb Australia Pty Ltd., Australia

Teva Canada Limited, Canada

6

Paroxetine

9th

Seroxat 20mg Tablet

S.C Europharm S.A, Romania

GlaxoSmithKline Pharmaceuticals S.A, Poland

 

5. Active pharmaceutical ingredient added to “Biowaivers granted based on unavailability/ inaccessibility of comparator/innovator product (List B)

iv) Dicyclomine HCl

 

]]>
jauze16@gmail.com (Jauze) Mon, 27 Aug 2018 09:43:58 +0800
Peringatan: Pelaksanaan Kawalan Regulatori Bahan Aktif Farmaseutikal (API) Untuk Produk Yang Tamat Tempoh Pendaftaran Mulai 1 Januari 2020 http://npra.moh.gov.my/index.php/announcement/1338-peringatan-pelaksanaan-kawalan-regulatori-bahan-aktif-farmaseutikal-api-untuk-produk-yang-tamat-tempoh-pendaftaran-mulai-1-januari-2020 http://npra.moh.gov.my/index.php/announcement/1338-peringatan-pelaksanaan-kawalan-regulatori-bahan-aktif-farmaseutikal-api-untuk-produk-yang-tamat-tempoh-pendaftaran-mulai-1-januari-2020
  • Direktif BPFK/PPP/01/03/J3(11) bertarikh 27 Jun 2014 adalah dirujuk.
  • Garispanduan untuk prosedur kawalan regulatori API boleh didapati di Guidance Notes Required Documents for API Information Version 2.0
  • Carta aliran untuk kawalan regulatori API ke atas produk berdaftar (yang mengandungi racun berjadual) boleh dirujuk.
  • Borang permohonan Form RegA1 (Application Form for Section S Revision for Product Registered Before the Implementation of Directive on Regulatory Control of API) akan berkuatkuasa mulai 1hb Oktober 2018. Borang ini boleh didapati di laman web NPRA (Garispanduan-API).
  • ]]>
    jauze16@gmail.com (Jauze) Tue, 07 Aug 2018 16:49:12 +0800
    New Publication: MADRAC Bulletin - Issue 01/2018 http://npra.moh.gov.my/index.php/announcement/1334-new-publication-madrac-bulletin-issue-01-2018 http://npra.moh.gov.my/index.php/announcement/1334-new-publication-madrac-bulletin-issue-01-2018

    MADRAC Bulletin - Issue 01/2018

     

    Features

    ▪ Recent Safety Issues with Fluoroquinolones

    Articles based on Case Reports

    ▪ Simvastatin: Reminder on the Risk of Cognitive Impairment
    ▪ Dipeptidyl Peptidase-4 Inhibitors: Reminder on the Risk of Pancreatitis
    ▪ Povidone-iodine Gargle: Risk of Hypothyroidism
    ▪ Adulteration of Traditional Products with Corticosteroids: Risk of Psychiatric Disorderst

    What’s New

    ▪ List of Directives Related to Drug Safety Issues (January - April 2018)

     

     

     

     


     

    drgd 
      DOWNLOAD PDF


    {pdf=http://npra.moh.gov.my/images/Publications/Newsletter_MADRAC_Bulletin/2018/MADRACBulletin012018.pdf|1120|1160|google}

    ]]>
    jauze16@gmail.com (Jauze) Mon, 30 Jul 2018 07:12:00 +0800
    Penipuan Kutipan Derma http://npra.moh.gov.my/index.php/announcement/1321-penipuan-kutipan-derma http://npra.moh.gov.my/index.php/announcement/1321-penipuan-kutipan-derma  

    1. Dimaklumkan bahawa terdapat individu tidak bertanggungjawab yang telah menggunakan nama NPRA untuk tujuan kutipan derma / sumbangan / tajaan
    2. NPRA tidak pernah memberi sokongan / bekerjasama  dengan mana-mana persatuan untuk tujuan derma / sumbangan / tajaan bagi kakitangan Kementerian Kesihatan Malaysia

     

    Nasihat NPRA

     

    1. Berhati-hati dan jangan mudah percaya dengan panggilan telefon atau surat oleh mana-mana pihak
    2. Untuk sebarang semakan dan pertanyaan lanjut, sila hubungi NPRA melalui saluran berikut:
    •  Talian AM  : 03 – 7883 5400 (Pertanyaan Umum)
    ]]>
    jauze16@gmail.com (Jauze) Fri, 13 Jul 2018 11:55:39 +0800
    Direktif Mengenai Penerimaan Pengesahan Pematuhan Amalan Perkilangan Baik (APB) Bagi Pegilang Farmaseutikal Bagi Tujuan Pendaftaran Baru/ Pendaftaran Semula Produk Farmaseutikal Berdaftar Dengan Pihak Berkuasa Kawalan Dadah (PBKD) http://npra.moh.gov.my/index.php/announcement/1299-direktif-mengenai-penerimaan-pengesahan-pematuhan-amalan-perkilangan-baik-apb-bagi-pegilang-farmaseutikal-bagi-tujuan-pendaftran-baru-pendaftaran-semula-produk-farmaseutiakl-berdaftar-dengan-pihak-berkuasa-kawalan-dadah-pbkd-2 http://npra.moh.gov.my/index.php/announcement/1299-direktif-mengenai-penerimaan-pengesahan-pematuhan-amalan-perkilangan-baik-apb-bagi-pegilang-farmaseutikal-bagi-tujuan-pendaftran-baru-pendaftaran-semula-produk-farmaseutiakl-berdaftar-dengan-pihak-berkuasa-kawalan-dadah-pbkd-2  

     

    {pdf=http://npra.moh.gov.my/images/Circulars_Directive/Regulatory_Information/2018/DirektifpenerimaanpengesahanpematuhanAPBbagipengilangfarmaseutikal.pdf|1120|1160|google}

     

     

     

     

     

    ]]>
    jauze16@gmail.com (Jauze) Wed, 16 May 2018 08:25:00 +0800
    PERINGATAN: Tarikh perlaksanaan kawalan regulatori API untuk permohonan baru produk generik yang mengandungi Racun Berjadual bagi produk dalam SEMUA bentuk dos berkuatkuasa 1 JULAI 2018. http://npra.moh.gov.my/index.php/announcement/1296-peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang-mengandungi-racun-berjadual-bagi-produk-dalam-semua-bentuk-dos-berkuatkuasa-1-julai-2018a http://npra.moh.gov.my/index.php/announcement/1296-peringatan-tarikh-perlaksanaan-kawalan-regulatori-api-untuk-permohonan-baru-produk-generik-yang-mengandungi-racun-berjadual-bagi-produk-dalam-semua-bentuk-dos-berkuatkuasa-1-julai-2018a             DOWNLOAD PDF         DOWNLOAD PDF ]]> jauze16@gmail.com (Jauze) Tue, 01 May 2018 00:31:00 +0800 2018 Education Seminar Series: Good Distribution Practice (GDP) http://npra.moh.gov.my/index.php/announcement/1292-2018-education-seminar-series-good-distribution-practice-gdp http://npra.moh.gov.my/index.php/announcement/1292-2018-education-seminar-series-good-distribution-practice-gdp

    Good Distribution Practice (GDP)

    7 May 2018 (Monday) | 9.00 am – 5.00 pm

    Venue

    THE ROYALE CHULAN DAMANSARA, Petaling Jaya

    Who should attend

    Manufacturers, importers, wholesalers and relevant parties involved in the storage / distribution of registered products and / or notified cosmetics

    Objectives

    • To highlight changes in the latest Guideline on GDP (3rd Edition, 2018)
    • To share NPRA’s experience on GDP inspections
    • To keep abreast of knowledge relevant to GDP

     

     

    Registration Fee

     

    (The fee includes course materials, lunch and refreshments)

     

     

     Ordinary ISPE Member : RM 750 
     Non ISPE Members  : RM 1,000
     Government Agencies & Academia ISPE Members  : RM 450
       

      Register Here


      DOWNLOAD PDF

     

      


     

     

     

    {pdf=http://npra.moh.gov.my/images/training-seminar/2018/FlyerISPE_GDP_final.pdf|1120|1160|google}

    ]]>
    Fri, 13 Apr 2018 12:35:00 +0800
    Berita Ubat-ubatan : March 2018, Volume 71 http://npra.moh.gov.my/index.php/announcement/1291-berita-ubat-ubatan-march-2018-volume-71 http://npra.moh.gov.my/index.php/announcement/1291-berita-ubat-ubatan-march-2018-volume-71
      DOWNLOAD PDF


     

     

     

    {pdf=http://npra.moh.gov.my/images/Publications/Newsletter_Berita_Ubat-ubatan/2018/BUUMAC18.pdf|1120|1160|google}

    ]]>
    Fri, 13 Apr 2018 08:35:00 +0800
    Berita Ubat-ubatan : December 2017, Volume 70 http://npra.moh.gov.my/index.php/announcement/1290-berita-ubat-ubatan-december-2017-volume-70 http://npra.moh.gov.my/index.php/announcement/1290-berita-ubat-ubatan-december-2017-volume-70
      DOWNLOAD PDF


     

     

     

    {pdf=http://npra.moh.gov.my/images/Publications/Newsletter_Berita_Ubat-ubatan/2017/BUUDEC17.pdf|1120|1160|google}

    ]]>
    Fri, 13 Apr 2018 08:30:00 +0800
    National Regulatory Conference (NRC) 2018 http://npra.moh.gov.my/index.php/announcement/1288-national-regulatory-conference-nrc-2018 http://npra.moh.gov.my/index.php/announcement/1288-national-regulatory-conference-nrc-2018  National Regulatory Conference (NRC) 2018

    Tuesday, 2 October 2018 until Thursday, 4 October 2018

     


    Theme :
    Regulatory Excellence : The New Normal

    Venue : 
    Hotel Royale Chulan Damansara, Selangor

    Contact person :
    Name : Ms. Balqis / Ms. Bavahrni / Mr. Kevin Heah

    Telephone : +603-7883 5535 / +603-7801 8475 / +603-7883 5540

    Email : nrcreg2018@gmail.com

    Organizer : 
    National Pharmaceutical Regulatory Agency (NPRA), Ministry Of Health

    Registration Fee :

    Category

    Fees

    (before 1st June)

    Fees

    (1st June onwards)

    Local Full Conference (3 Days) : MYR 1525 MYR 1430
    Local Single Track  (TMHS ONLY, 1 DAY) : MYR 1000 MYR 940
    Overseas (full conference) : USD 550 USD 515
    Government : MYR 700 MYR 650
    Student : MYR 500 MYR 470

     

     REGISTRATION IS CLOSED. 

     

     

      TENTATIVE AGENDA FOR NATIONAL REGULATORY CONFERENCE (NRC) 2018*

     

    {pdf=http://npra.moh.gov.my/images/Announcement/2018/nrc/TENTATIF-PROGRAM-NRC-2018.pdf|1200|1120|google}

     *subject to changes

    ]]>
    jauze16@gmail.com (Jauze) Mon, 09 Apr 2018 15:22:00 +0800
    Berita Ubat-ubatan : September 2017, Volume 69 http://npra.moh.gov.my/index.php/announcement/1289-berita-ubat-ubatan-september-2017-volume-69 http://npra.moh.gov.my/index.php/announcement/1289-berita-ubat-ubatan-september-2017-volume-69
      DOWNLOAD PDF


     

     

     

    {pdf=http://npra.moh.gov.my/images/Publications/Newsletter_Berita_Ubat-ubatan/2017/BUUSEPT17.pdf|1120|1160|google}

    ]]>
    Fri, 13 Apr 2018 08:19:00 +0800
    Latihan untuk Industri: Pemeriksaan APB Pengilang Veterinar http://npra.moh.gov.my/index.php/announcement/1287-latihan-untuk-industri-pemeriksaan-apb-pengilang-veterinar http://npra.moh.gov.my/index.php/announcement/1287-latihan-untuk-industri-pemeriksaan-apb-pengilang-veterinar

    Pemeriksaan Apb Pengilang Veterinar & Keperluan Pemeriksaan Apb Pengilang Veterinar

    24 & 25 April 2018 (Selasa & Rabu)

     

    Objectives

    1.     Memberi pendedahan kepada pengilang berkenaan direktif dan garis panduan terkini berkaitan pemeriksaan APB premis pengilang produk veterinar.

    2.     Meningkatkan kefahaman pengilang produk veterinar berkenaan keperluan APB.

    3.   Memberi peluang kepada pengilang dan NPRA untuk berkongsi isu-isu berkaitan pemeriksaan APB.

     

     

    Venue    : Royale Chulan Damansara,Petaling Jaya

     

    Time      : 9.00 pagi – 5.00 petang

     

     


      REGISTER HERE

     


     

    drgd 
      DOWNLOAD FLIER


    {pdf=http://npra.moh.gov.my/images/Images/Banner/2018/FlyerISPEVeterinaryApr2018.pdf|1120|1160|google}

     

    ]]>
    jauze16@gmail.com (Jauze) Thu, 05 Apr 2018 15:22:23 +0800
    MAKLUMAN SCAM PANGGILAN TELEFON http://npra.moh.gov.my/index.php/announcement/1286-makluman-scam-panggilan-telefon http://npra.moh.gov.my/index.php/announcement/1286-makluman-scam-panggilan-telefon Sejak kebelakangan ini, Bahagian Regulatori Farmasi Negara (NPRA) telah menerima laporan berkaitan kes penipuan atau scam menggunakan panggilan telefon. Didapati bahawa terdapat pelanggan NPRA yang telah menerima panggilan telefon daripada suspek yang mendakwa mereka sebagai pegawai NPRA melalui talian 03 – 7883 5400 atau lain-lain nombor yang seolah-olah merupakan panggilan daripada NPRA. Seterusnya, suspek ini telah meminta nombor kad pengenalan diri serta maklumat lain daripada mangsa.

    NASIHAT NPRA:

     

    1.    Bertenang dan ingat sama ada anda mempunyai sebarang urusan dengan NPRA atau tidak. Jika tidak, abaikan panggilan tersebut.

    2.    Jangan mendedahkan apa-apa maklumat peribadi seperti nombor kad pengenalan, pasport, nombor akaun bank dan sebagainya.

    3.    Berhati-hati dan jangan mudah percaya dengan panggilan telefon oleh mana-mana pihak yang mendakwa diri mereka sebagai Pegawai NPRA.

    4.    Jangan menghubungi semula sebarang nombor telefon yang diberikan oleh pihak berkenaan sebaliknya buat semakan dengan NPRA melalui talian yang betul.

    5.    Untuk sebarang semakan dan pertanyaan lanjut, sila hubungi NPRA melalui saluran berikut:

     

    --------------------------------------------------------------------------------------------------------------------------------------------------------------------

     

     

    NOTICE

     

    SCAM TELEPHONE CALLS

     

    Recently, the National Pharmaceutical Regualtory Division (NPRA) has received reports from the public regarding scam telephone calls that were made by individuals who claimed to be NPRA officers. The telephone numbers that appeared on the victims’ phones were from 03 – 7883 5400 and other NPRA related numbers which made the calls seemingly viable. These individuals would then request for verification of IC numbers and / or other personal information from the victims.

     

    NPRA’S ADVICE:

     

    1.    Keep calm and try to recall whether you have had any recent official dealings with NPRA. If not, kindly ignore the telephone call.

    2.    Do not expose any personal details over the phone, for example, your identity card number, passport number, bank account number etc.

    3.    Be wary and cautious if you receive any telephone calls from individuals claiming to be NPRA officers.

    4.    Do not return calls to NPRA using the phone numbers given by these individuals over the phone. Instead, check back via the NPRA official website for the correct phone numbers to call.

    5.    For any further enquiries, kindly contact the NPRA via the following channels:

     

     

    ]]>
    jauze16@gmail.com (Jauze) Thu, 05 Apr 2018 12:01:00 +0800
    New Safety Alerts for Healthcare Professionals http://npra.moh.gov.my/index.php/announcement/1285-new-safety-alerts-for-healthcare-professionals http://npra.moh.gov.my/index.php/announcement/1285-new-safety-alerts-for-healthcare-professionals New Safety Alerts Update :

    1. Levetiracetam and Methotrexate: Risk of Drug-drug Interaction
    2. Intravenous (IV) Fluids Containing Electrolytes and/or Carbohydrates: Risk of Hyponatraemia
    3. Gadolinium-based Contrast Agents: Suspension / Restriction of Use Following Evidence of Gadolinium Deposits in the Brain after Magnetic Resonance Imaging (MRI) Body Scans
    4. Doxycycline: Risk of Jarisch-Herxheimer Reaction

     

     

      More Safety Alerts

    ]]>
    jauze16@gmail.com (Jauze) Fri, 23 Mar 2018 15:14:29 +0800